기본 통계
| LEI | 54930050DETB6CP71D38 |
| CIK | 1021561 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Nu Skin Enterprises, Inc.
SEC Filings (Chronological Order)
이 페이지는 다른 곳에서 제공하는 소유권 보고서를 제외한 SEC 보고서의 전체 리스트를 시간 순으로 정리한 것입니다.
| June 1, 2026 |
As filed with the Securities and Exchange Commission on June 1, 2026. As filed with the Securities and Exchange Commission on June 1, 2026. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 87-0565309 (State or other jurisdiction of incorporation or organization) (I.R.S. |
|
| June 1, 2026 |
Exhibit 107.1 CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) Nu Skin Enterprises, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price(2) Fee Rate Amount of Registration Fee Equity Class A Common |
|
| May 29, 2026 |
Exhibit 10.1 NU SKIN ENTERPRISES, INC. AMENDED AND RESTATED 2024 OMNIBUS INCENTIVE PLAN Stockholder Approval: May 28, 2026 Expiration Date: May 28, 2036 Nu Skin Enterprises, Inc. (the “Company”), a Delaware corporation, hereby establishes and adopts the following Amended and Restated 2024 Omnibus Incentive Plan. 1 PURPOSE OF THE PLAN The purpose of the Plan is to assist the Company and its Subsidi |
|
| May 29, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 28, 2026 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission F |
|
| May 21, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 (State or other jurisdiction of incorporation) (Commission File Number) 75 West Center Street Provo, Utah 84601 (Address of principal executive offices and zip code) Gregory Belliston, (801) |
|
| May 21, 2026 |
NU SKIN ENTERPRISES, INC. 2025 CONFLICT MINERALS REPORT May 21, 2026 EXHIBIT 1.01 NU SKIN ENTERPRISES, INC. 2025 CONFLICT MINERALS REPORT May 21, 2026 We prepared this 2025 Conflict Minerals Report pursuant to Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”), which was promulgated in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 to impose reporting, disclosure and other requirements on registrants that manufa |
|
| May 8, 2026 |
SECOND AMENDMENT AND RESTATEMENT AGREEMENT Exhibit 10.1 SECOND AMENDMENT AND RESTATEMENT AGREEMENT This SECOND AMENDMENT AND RESTATEMENT AGREEMENT, dated as of March 27, 2026 (this “Restatement Agreement”), in respect of the Credit Agreement, dated as of April 18, 2018 (as amended and restated by that certain Amendment and Restatement Agreement, dated as of the 2022 Closing Date and as further amended, supplemented or modified prior to the |
|
| May 8, 2026 |
NU SKIN ENTERPRISES, INC. 2024 OMNIBUS INCENTIVE PLAN, AS AMENDED RESTRICTED STOCK UNIT AGREEMENT Exhibit 10.2 NU SKIN ENTERPRISES, INC. 2024 OMNIBUS INCENTIVE PLAN, AS AMENDED RESTRICTED STOCK UNIT AGREEMENT This Restricted Stock Unit Agreement, Participant’s award information (the “Award Summary”), which can be accessed on the Fidelity website (currently www.fidelity.com) or the website of such other stock plan administrator(s) that the Company may select in the future, and the Appendix for |
|
| May 8, 2026 |
Exhibit 10.3 NU SKIN ENTERPRISES, INC. 2024 OMNIBUS INCENTIVE PLAN, AS AMENDED PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT This Performance Restricted Stock Unit Agreement, Participant’s award information (the “Award Summary”), which can be accessed on the Fidelity website (currently www.fidelity.com) or the website of such other stock plan administrator(s) that the Company may select in the futur |
|
| May 8, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| May 8, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 6, 2026 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission Fi |
|
| May 7, 2026 |
Nu Skin Enterprises Reports First Quarter Results Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports First Quarter Results PROVO, Utah — May 7, 2026 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced first quarter revenue results within its guidance range. Executive Summary Q1 2026 vs. Prior-year Quarter Revenue $320.6 million; (12.0)% • +1.1% FX impact or $3.9 million Earnings Per Share (EPS) $0.04 or $0.14 excluding certain char |
|
| May 7, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 7, 2026 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission Fi |
|
| April 3, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 3, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 3, 2026 |
2025 ANNUAL REPORT TO STOCKHOLDERS. ANNUAL REPORT 2025Dear shareholder, For more than four decades, Nu Skin has pursued its mission to be a global force for good by empowering people to look, feel and live better lives. |
|
| March 27, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 27, 2026 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| March 27, 2026 |
SECOND AMENDMENT AND RESTATEMENT AGREEMENT Exhibit 10.1 SECOND AMENDMENT AND RESTATEMENT AGREEMENT This SECOND AMENDMENT AND RESTATEMENT AGREEMENT, dated as of March 27, 2026 (this “Restatement Agreement”), in respect of the Credit Agreement, dated as of April 18, 2018 (as amended and restated by that certain Amendment and Restatement Agreement, dated as of the 2022 Closing Date and as further amended, supplemented or modified prior to the |
|
| March 20, 2026 |
Nu Skin Enterprises Appoints Chelsea Lantz as Interim Chief Financial Officer Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Appoints Chelsea Lantz as Interim Chief Financial Officer PROVO, Utah — March 20, 2026 — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the appointment of Chelsea Lantz as interim Chief Financial Officer, effective immediately. The appointment of Lantz comes after James Thomas stepped down as CFO to pursue an outside opportunity. “On be |
|
| March 20, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 17, 2026 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| March 9, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 5, 2026 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| March 9, 2026 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Appoints Chayce Clark as COO Clark to expand on his responsibilities as chief legal officer to oversee company operational functions and revenue performance PROVO, Utah — March 9, 2026 — Nu Skin Enterprises Inc. (NYSE:NUS) today announced the appointment of Chayce Clark as chief operating officer effective immediately. Clark will be responsible for leadin |
|
| February 13, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| February 13, 2026 |
SUBSIDIARIES OF THE REGISTRANT Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT Beauty Biosciences LLC , a Texas limited liability company Big Planet, Inc., a Delaware corporation Corner Canyon Canada, Inc., an Ontario corporation Corner Canyon Manufacturing, Inc., a Utah corporation Elevate Nutraceuticals LLC, a Utah limited liability company Grōv Technologies, LLC, a Utah limited liability company Grow Solutions Tech LLC, a Utah l |
|
| February 12, 2026 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance Company provides initial outlook for Q1 and fiscal year 2026, forecasting a return to revenue growth by year’s end PROVO, Utah — Feb. 12, 2026 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2025 revenue and earnings within guidance with more |
|
| February 12, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 12, 2026 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commiss |
|
| November 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| November 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 6, 2025 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissi |
|
| November 6, 2025 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Third Quarter Earnings Company preparing for limited introduction of Prysm iO and pre-market opening of India in the fourth quarter PROVO, Utah — Nov. 6, 2025 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced third quarter revenue and earnings per share within its guidance range. Executive Summary Q3 2025 vs. Prior-year Quarter Re |
|
| September 4, 2025 |
144 0001778431 XXXXXXXX LIVE 0001021561 NU SKIN ENTERPRISES, INC. 001-12421 75 WEST CENTER ST ATTN: GREGORY BELLISTON PROVO UT 84601 801-345-1000 Nathanson Laura Director Class A William Blair 150 N Riverside PLZ CHicago IL 60606 6489 77868.00 49497715 09/04/2025 NYSE Class A 04/30/2021 Payment Issuer N 422 04/30/2021 Compensation Class A 04/30/2022 Payment Issuer N 2467 04/30/2022 Compensation Cl |
|
| September 3, 2025 |
144 0001873048 XXXXXXXX LIVE 0001021561 NU SKIN ENTERPRISES, INC. 001-12421 75 WEST CENTER ST ATTN: GREGORY BELLISTON PROVO UT 84601 801-345-1000 Clark Chayce David Officer Class A Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917 20000 239433.56 49497715 09/03/2025 NYSE Class A 02/15/2022 Restricted Stock Vesting Issuer N 1756 02/15/2022 Compensation Class A 06/05/2022 Restrict |
|
| August 29, 2025 |
144 0001184200 XXXXXXXX LIVE 0001021561 NU SKIN ENTERPRISES, INC. 001-12421 75 WEST CENTER STREET PROVO UT 84601 801-345-1000 CAMPBELL GIFT TRUST Director Common Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004 23391 283117.65 49497715 08/29/2025 NYSE Common 11/02/2021 Gift from Affiliate DANIEL CAMPBELL Y 05/26/2017 2448 NA Common 11/02/202 |
|
| August 29, 2025 |
144 0001184200 XXXXXXXX LIVE 0001021561 NU SKIN ENTERPRISES, INC. 001-12421 75 WEST CENTER STREET PROVO UT 84601 801-345-1000 DANIEL WAYNE CAMPBELL & PEGGY CAMPBELL Director Common Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004 9046 109635.71 49497715 08/29/2025 NYSE Common 04/24/2012 Restricted stock vesting under a registered plan Issuer |
|
| August 8, 2025 |
NU SKIN ENTERPRISES, INC. 2024 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT Exhibit 10.2 NU SKIN ENTERPRISES, INC. 2024 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT This Restricted Stock Unit Agreement and Participant’s award information (the “Award Summary”), which can be accessed on the Fidelity website (currently www.fidelity.com) or the website of such other stock plan administrator(s) that the Company may select in the future, (collectively, this “Agreement |
|
| August 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 7, 2025 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| August 7, 2025 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Second Quarter Revenue at High End of Guidance and Earnings Per Share Above Guidance Company generates strong operating margin and cash position; narrows revenue and raises EPS guidance PROVO, Utah — August 7, 2025 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced second quarter revenue at the high end of its guidance range and ea |
|
| June 2, 2025 |
As filed with the Securities and Exchange Commission on June 2, 2025. As filed with the Securities and Exchange Commission on June 2, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 87-0565309 (State or other jurisdiction of incorporation or organization) (I.R.S. |
|
| June 2, 2025 |
Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Nu Skin Enterprises, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1 – Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price(2) Fee Rate Amount of Registration Fee Equity Class A Commo |
|
| May 30, 2025 |
Exhibit 10.1 NU SKIN ENTERPRISES, INC. AMENDED AND RESTATED 2024 OMNIBUS INCENTIVE PLAN Stockholder Approval: May 29, 2025 Expiration Date: May 29, 2035 Nu Skin Enterprises, Inc. (the “Company”), a Delaware corporation, hereby establishes and adopts the following Amended and Restated 2024 Omnibus Incentive Plan. 1 PURPOSE OF THE PLAN The purpose of the Plan is to assist the Company and its Subsidi |
|
| May 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 29, 2025 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission F |
|
| May 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 (State or other jurisdiction of incorporation) (Commission File Number) 75 West Center Street Provo, Utah 84601 (Address of principal executive offices and zip code) Gregory Belliston, (801) |
|
| May 27, 2025 |
EXHIBIT 1.01 NU SKIN ENTERPRISES, INC. 2024 CONFLICT MINERALS REPORT May 27, 2025 We prepared this 2024 Conflict Minerals Report pursuant to Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”), which was promulgated in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 to impose reporting, disclosure and other requirements on registrants that manufa |
|
| May 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| May 8, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 8, 2025 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission Fi |
|
| May 8, 2025 |
Nu Skin Enterprises Reports First Quarter Revenue at High End of Guidance Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports First Quarter Revenue at High End of Guidance PROVO, Utah — May 8, 2025 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced first quarter revenue at the high end of its guidance range. Executive Summary Q1 2025 vs. Prior-year Quarter Revenue $364.5 million; (12.7)% • (3.0)% FX impact or $(12.3) million Earnings Per Share (EPS) $2.14 |
|
| April 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 4, 2025 |
2024 ANNUAL REPORT TO STOCKHOLDERS DEAR SHAREHOLDER, In our 40th year at Nu Skin Enterprises of pursuing our mission to be a global force for good by empowering people to look, feel and live better lives, I find myself to be even more invigorated about our future than ever before! As the landscape rapidly evolves due to new technologies like AI, changing foreign trade policies and integrated connection and shopping mediums like TikTok, some view the world as chaotic and uncertain. |
|
| March 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 5, 2025 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| February 14, 2025 |
Nu Skin Enterprises, Inc. Securities Trading Policy. Exhibit 19.1 Nu Skin Enterprises, Inc. Securities Trading Policy This Securities Trading Policy (the “Policy”) provides guidelines with respect to transactions in the securities of Nu Skin Enterprises, Inc. (the “Company”) and the handling of confidential information about the Company and the companies with which the Company does business. The purpose of this Policy is to promote compliance with f |
|
| February 14, 2025 |
Exhibit 10.16 NU SKIN ENTERPRISES, INC. EXECUTIVE SEVERANCE POLICY Amended and Restated Effective as of January 4, 2023 TABLE OF CONTENTS PAGE SECTION 1. DEFINITIONS 1 SECTION 2. TERM OF POLICY 5 SECTION 3. TERMINATION BY COMPANY WITHOUT CAUSE OR BY EXECUTIVE FOR GOOD REASON 5 SECTION 4. TERMINATION BY REASON OF DEATH OR DISABILITY 7 SECTION 5. TERMINATION BY THE COMPANY FOR CAUSE 7 SECTION 6. VOL |
|
| February 14, 2025 |
Form of 2024 Plan Director Restricted Stock Unit Grant Agreement. Exhibit 10.11 NU SKIN ENTERPRISES, INC. 2024 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT This Restricted Stock Unit Agreement, Participant’s award information (the “Award Summary”), which can be accessed on the Fidelity website (currently www.fidelity.com) or the website of any other stock plan administrator selected by the Company in the future, and the Appendix for Participant’s count |
|
| February 14, 2025 |
Form of 2024 Plan Restricted Stock Unit Grant Agreement. Exhibit 10.9 NU SKIN ENTERPRISES, INC. 2024 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT This Restricted Stock Unit Agreement, Participant’s award information (the “Award Summary”), which can be accessed on the Fidelity website (currently www.fidelity.com) or the website of such other stock plan administrator(s) that the Company may select in the future, and the Appendix for Participant’ |
|
| February 14, 2025 |
Form of 2024 Plan Performance Restricted Stock Unit Grant Agreement. Exhibit 10.10 NU SKIN ENTERPRISES, INC. 2024 OMNIBUS INCENTIVE PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT This Performance Restricted Stock Unit Agreement, Participant’s award information (the “Award Summary”), which can be accessed on the Fidelity website (currently www.fidelity.com) or the website of such other stock plan administrator(s) that the Company may select in the future, and the |
|
| February 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| February 14, 2025 |
Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT Beauty Biosciences LLC , a Texas limited liability company Big Planet, Inc., a Delaware corporation Corner Canyon Canada, Inc., an Ontario corporation Corner Canyon Manufacturing, Inc., a Utah corporation Elevate Nutraceuticals LLC, a Utah limited liability company Grōv Technologies, LLC, a Utah limited liability company Grow Solutions Tech LLC, a Utah l |
|
| February 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 13, 2025 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commiss |
|
| February 13, 2025 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Fourth Quarter and Full-year 2024 Results Above Company Revenue Guidance Company provides initial outlook for Q1 and FY 2025 PROVO, Utah — Feb. 13, 2025 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2024 results above its latest revenue guidance. Executive Summary Q4 2024 vs. Prior-year Quarter Rev |
|
| January 13, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 13, 2025 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissi |
|
| January 13, 2025 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance Company to discuss performance, strategy and opportunities at ICR Conference; full financial results to be announced Feb. 13 PROVO, Utah — Jan. 13, 2025 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced Q4 2024 preliminary revenue at the high end of the company’s guidance range ahea |
|
| January 3, 2025 |
Nu Skin Enterprises Announces Strategic Transaction of Mavely for $250 Million Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Announces Strategic Transaction of Mavely for $250 Million PROVO, Utah — Jan. 3, 2025 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced that its Rhyz Inc. subsidiary completed a strategic transaction with Later, a portfolio company of Summit Partners. As part of the transaction, Rhyz sold its Mavely affiliate marketing technology platform |
|
| January 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 January 2, 2025 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissio |
|
| January 3, 2025 |
Exhibit 2.1 UNIT PURCHASE AGREEMENT BY AND AMONG MAVELY SELLER LLC, MAVELY LLC, CLOUT.IO HOLDINGS, INC., and MAVRCK LLC Dated as of January 2, 2025 TABLE OF CONTENTS Page Article I CERTAIN DEFINITIONS 2 1.1 Definitions 2 Article II UNIT purchase 21 2.1 Unit Purchase 21 2.2 Closing 21 2.3 Closing Payments by Purchaser 22 2.4 Certain Indebtedness and Liens 23 2.5 Post-Closing Determination of Additi |
|
| January 3, 2025 |
SELECTED UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION Exhibit 99.2 SELECTED UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION On January 2, 2025, Nu Skin Enterprises, Inc. (“Nu Skin” “we” or the “Company”), through our consolidated subsidiary Mavely Seller LLC (“Seller”), entered into a Unit Purchase Agreement, dated as of January 2, 2025 (the “Purchase Agreement”), by and among Seller, Mavely LLC (“Mavely”), Clout.io Holdings, Inc. (“ |
|
| November 12, 2024 |
NUS / Nu Skin Enterprises, Inc. / VANGUARD GROUP INC Passive Investment SC 13G/A 1 UnitedStates13GNuSkinEnte.txt 240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to 240.13d-1(b), (c), and (d) and amendments thereto filed pursuant to 240.13d-2. Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 15)* (Name of Issuer) Nu Skin Enterprises Inc (Title of Class of |
|
| November 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| November 7, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 7, 2024 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissi |
|
| November 7, 2024 |
Nu Skin Enterprises Reports Third Quarter Results Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Third Quarter Results PROVO, Utah — Nov. 7, 2024 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced third quarter results in line with guidance. Executive Summary Q3 2024 vs. Prior-year Quarter Revenue $430.1 million; (13.8)% • (3.4)% FX impact or $(16.7) million • Rhyz revenue $73.1 million; 20.9% Earnings Per Share (EPS) $0.17 co |
|
| November 6, 2024 |
NUS / Nu Skin Enterprises, Inc. / Invesco Ltd. - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Nu Skin Enterprises Inc (Name of Issuer) Common Stock (Title of Class of Securities) 67018T105 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| November 4, 2024 |
NUS / Nu Skin Enterprises, Inc. / VANGUARD GROUP INC Passive Investment SC 13G/A 1 UnitedStates13GNuSkinEnte.txt 240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to 240.13d-1(b), (c), and (d) and amendments thereto filed pursuant to 240.13d-2. Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 14)* (Name of Issuer) Nu Skin Enterprises Inc (Title of Class of |
|
| November 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 31, 2024 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissi |
|
| November 1, 2024 |
Exhibit 3.1 SIXTH AMENDED AND RESTATED BYLAWS OF NU SKIN ENTERPRISES, INC. ARTICLE 1. STOCKHOLDERS 1.1 Place of Meetings. Meetings of stockholders shall be held: (i) at such place within or without the State of Delaware as may be designated by or in the manner provided in the Certificate of Incorporation of the Corporation, as amended and/or restated from time to time (the “Certificate of Incorpor |
|
| October 18, 2024 |
NUS / Nu Skin Enterprises, Inc. / STATE STREET CORP Passive Investment SC 13G/A 1 NuSkinEnterprisesInc.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* NU SKIN ENTERPRISES INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 67018T105 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule |
|
| October 7, 2024 |
NUS / Nu Skin Enterprises, Inc. / BlackRock, Inc. Passive Investment SC 13G/A 1 us67018t1051100724.txt us67018t1051100724.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 11) NU SKIN ENTERPRISES INC - (Name of Issuer) Class A Common Stock - (Title of Class of Securities) 67018T105 - (CUSIP Number) September 30, 2024 - (Date of Event Which Requires Filing of this Statement) Check the |
|
| September 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 10, 2024 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commis |
|
| August 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| August 8, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 8, 2024 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| August 8, 2024 |
Nu Skin Enterprises Reports Second Quarter Results Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Second Quarter Results PROVO, Utah — Aug. 8, 2024 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced second quarter results in line with top-line guidance. Executive Summary Q2 2024 vs. Prior-year Quarter Revenue $439.1 million; (12.2)% • (4.2)% FX impact or $(21.0) million • Rhyz revenue $67.8 million; 32.3% Earnings Per Share (EP |
|
| June 7, 2024 |
As filed with the Securities and Exchange Commission on June 7, 2024 Registration No. 333- As filed with the Securities and Exchange Commission on June 7, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S‑8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 87-0565309 (I.R.S. |
|
| June 7, 2024 |
As filed with the Securities and Exchange Commission on June 7, 2024 Registration No. 333-167690 Registration No. 333-190508 Registration No. 333-211617 Registration No. 333-238908 Registration No. 333-280044 As filed with the Securities and Exchange Commission on June 7, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S‑8 REGISTRATION STATEMENT NO. 333-167690 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM |
|
| June 7, 2024 |
As filed with the Securities and Exchange Commission on June 7, 2024 Registration No. 333-167690 Registration No. 333-190508 Registration No. 333-211617 Registration No. 333-238908 Registration No. 333-280044 As filed with the Securities and Exchange Commission on June 7, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S‑8 REGISTRATION STATEMENT NO. 333-167690 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM |
|
| June 7, 2024 |
As filed with the Securities and Exchange Commission on June 7, 2024 Registration No. 333-167690 Registration No. 333-190508 Registration No. 333-211617 Registration No. 333-238908 Registration No. 333-280044 As filed with the Securities and Exchange Commission on June 7, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S‑8 REGISTRATION STATEMENT NO. 333-167690 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM |
|
| June 7, 2024 |
Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Nu Skin Enterprises, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1 – Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price(2) Fee Rate Amount of Registration Fee Equity Class A Commo |
|
| June 7, 2024 |
As filed with the Securities and Exchange Commission on June 7, 2024 Registration No. 333-167690 Registration No. 333-190508 Registration No. 333-211617 Registration No. 333-238908 Registration No. 333-280044 As filed with the Securities and Exchange Commission on June 7, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S‑8 REGISTRATION STATEMENT NO. 333-167690 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM |
|
| June 7, 2024 |
As filed with the Securities and Exchange Commission on June 7, 2024 Registration No. 333-167690 Registration No. 333-190508 Registration No. 333-211617 Registration No. 333-238908 Registration No. 333-280044 As filed with the Securities and Exchange Commission on June 7, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S‑8 REGISTRATION STATEMENT NO. 333-167690 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM |
|
| June 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 5, 2024 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission F |
|
| June 6, 2024 |
Exhibit 10.1 2024 OMNIBUS INCENTIVE PLAN Stockholder Approval: June 5, 2024 Expiration Date: June 5, 2034 Nu Skin Enterprises, Inc. (the “Company”), a Delaware corporation, hereby establishes and adopts the following 2024 Omnibus Incentive Plan (the “Plan”). 1 PURPOSE OF THE PLAN The purpose of the Plan is to assist the Company and its Subsidiaries in attracting and retaining selected individuals |
|
| May 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 (State or other jurisdiction of incorporation) (Commission File Number) 75 West Center Street Provo, Utah 84601 (Address of principal executive offices and zip code) Gregory Belliston, (801) |
|
| May 29, 2024 |
EXHIBIT 1.01 NU SKIN ENTERPRISES, INC. 2023 CONFLICT MINERALS REPORT May 29, 2024 We prepared this 2023 Conflict Minerals Report pursuant to Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”), which was promulgated in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 to impose reporting, disclosure and other requirements on registrants that manufa |
|
| May 9, 2024 |
Exhibit 10.1 CONSULTING AGREEMENT This Consulting Agreement (this “Agreement”) is entered into effective as of March 30, 2024 (the “Effective Date”), by and between Nu Skin Enterprises, Inc., a Delaware corporation (the “Company”) and Joseph Y. Chang, an individual (“Consultant”). The Company and Employee are sometimes hereinafter referred to as “party” or “parties.” RECITALS A. Prior to the termi |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| May 8, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 8, 2024 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission Fi |
|
| May 8, 2024 |
Nu Skin Enterprises Reports First Quarter Results Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports First Quarter Results PROVO, Utah — May 8, 2024 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced first quarter results in line with guidance. Executive Summary Q1 2024 vs. Prior-year Quarter Revenue $417.3 million; (13.3)% • (3.8)% FX impact or $(18.2) million • Rhyz revenue $62.5 million; 57.5% Earnings Per Share (EPS) $(0.01) o |
|
| April 12, 2024 |
ANNUAL REPORT 2023DEAR SHAREHOLDER, As I reflect on the past year, 2023 was marked by resilience, innovation and an unwavering commitment toward our mission of being a global force for good by empowering people to improve lives. |
|
| April 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 15, 2024 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| February 15, 2024 |
EXHIBIT 21.1 SUBSIDIARIES OF THE REGISTRANT Beauty Biosciences LLC , a Texas limited liability company Big Planet, Inc., a Delaware corporation Corner Canyon Canada, Inc., an Ontario corporation Corner Canyon Manufacturing, Inc., a Utah corporation Elevate Nutraceuticals LLC, a Utah limited liability company Grōv Technologies, LLC, a Utah limited liability company Grow Solutions Tech LLC, a Utah l |
|
| February 15, 2024 |
Exhibit 10.13 NU SKIN ENTERPRISES, INC. EXECUTIVE SEVERANCE POLICY Amended and Restated Effective as of January 4, 2023 TABLE OF CONTENTS PAGE SECTION 1. DEFINITIONS 1 SECTION 2. TERM OF POLICY 5 SECTION 3. TERMINATION BY COMPANY WITHOUT CAUSE OR BY EXECUTIVE FOR GOOD REASON 5 SECTION 4. TERMINATION BY REASON OF DEATH OR DISABILITY 7 SECTION 5. TERMINATION BY THE COMPANY FOR CAUSE 7 SECTION 6. VOL |
|
| February 15, 2024 |
EXHIBIT 4.2 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2023, Nu Skin Enterprises, Inc. (the “Company”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): Class A Common Stock. This class of securities has a par value of $0.001 per share |
|
| February 15, 2024 |
Form of Third Amended and Restated 2010 Plan Restricted Stock Unit Grant Agreement. Exhibit 10.5 NU SKIN ENTERPRISES, INC. THIRD AMENDED AND RESTATED 2010 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT This Restricted Stock Unit Agreement, Participant’s award information (the “Award Summary”), which can be accessed on the Fidelity website (currently www.fidelity.com) or the website of any other stock plan administrator selected by the Company in the future, and the Append |
|
| February 15, 2024 |
Form of Third Amended and Restated 2010 Plan Performance Restricted Stock Unit Grant Agreement. Exhibit 10.6 NU SKIN ENTERPRISES, INC. THIRD AMENDED AND RESTATED 2010 OMNIBUS INCENTIVE PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT This Performance Restricted Stock Unit Agreement, Participant’s award information (the “Award Summary”), which can be accessed on the Fidelity website (currently www.fidelity.com) or the website of any other stock plan administrator selected by the Company in th |
|
| February 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| February 15, 2024 |
Nu Skin Enterprises, Inc. Executive Officer Incentive Compensation Recovery Policy. Exhibit 97.1 NU SKIN ENTERPRISES, INC. Executive Officer Incentive Compensation Recovery Policy (Adopted November 9, 2023) A. Purpose The Compensation and Human Capital Committee (the “Committee”) of the Board of Directors (the “Board”) of Nu Skin Enterprises, Inc., a Delaware corporation (the “Company”), has adopted this policy (this “Policy”) to require the recovery of certain executive compensa |
|
| February 14, 2024 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Fourth Quarter and Full-year 2023 Results Above Company Guidance Company updates capital allocation priorities, announces dividend and provides initial outlook for Q1 and FY 2024 PROVO, Utah — Feb. 14, 2024 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2023 results slightly above its latest guidanc |
|
| February 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 9, 2024 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissi |
|
| February 13, 2024 |
NUS / Nu Skin Enterprises, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 13)* Name of issuer: Nu Skin Enterprises, Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 67018T105 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 9, 2024 |
NUS / Nu Skin Enterprises, Inc. / Invesco Ltd. - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Nu Skin Enterprises Inc (Name of Issuer) Common Stock (Title of Class of Securities) 67018T105 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| February 9, 2024 |
Invesco Joint Filing Agreement JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) (l) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing of the attached Schedule 13G, and any and all amendments thereto, and expressly authorize Invesco Ltd. |
|
| February 8, 2024 |
SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* Nu Skin Enterprises, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 67018T105 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appr |
|
| February 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 5, 2024 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissi |
|
| February 6, 2024 |
Exhibit 3.1 FIFTH AMENDED AND RESTATED BYLAWS OF NU SKIN ENTERPRISES, INC. ARTICLE 1. STOCKHOLDERS 1.1 Place of Meetings. Meetings of stockholders shall be held: (i) at such place within or without the State of Delaware as may be designated by or in the manner provided in the Certificate of Incorporation of the Corporation, as amended and/or restated from time to time (the “Certificate of Incorpor |
|
| January 25, 2024 |
NUS / Nu Skin Enterprises, Inc. / STATE STREET CORP Passive Investment SC 13G/A 1 NuSkinEnterp.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 AMENDED FILING NU SKIN ENTERPRISES INC (NAME OF ISSUER) COMMON STOCK (TITLE OF CLASS OF SECURITIES) 67018T105 (CUSIP NUMBER) 12/31/2023 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSU |
|
| January 22, 2024 |
NUS / Nu Skin Enterprises, Inc. / BlackRock Inc. Passive Investment SC 13G/A 1 us67018t1051012224.txt us67018t1051012224.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 10) NU SKIN ENTERPRISES INC - (Name of Issuer) Class A Common Stock - (Title of Class of Securities) 67018T105 - (CUSIP Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the a |
|
| January 8, 2024 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises to Discuss Company Strategy and Opportunities at ICR Conference Company announces Q4 preliminary revenue slightly above guidance with full financial results to be announced Feb. 14 PROVO, Utah — Jan. 8, 2024 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced President and CEO Ryan Napierski and Chief Financial Officer James D. Thomas will |
|
| January 8, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 8, 2024 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissio |
|
| November 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| November 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 27, 2023 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissi |
|
| November 1, 2023 |
Nu Skin Enterprises Reports Third Quarter 2023 Financial Results Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Third Quarter 2023 Financial Results PROVO, Utah — Nov. 1, 2023 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced third quarter 2023 results. Executive Summary Q3 2023 vs. Prior-year Quarter Revenue $498.8 million; (7)% • (1)% FX impact or $(8.1) million Earnings Per Share (EPS) $(0.74) or $0.56 excluding an inventory write-off co |
|
| August 9, 2023 |
NUS / Nu Skin Enterprises, Inc. - Class A / STATE STREET CORP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 AMENDED FILING NU SKIN ENTERPRISES INC (NAME OF ISSUER) COMMON STOCK (TITLE OF CLASS OF SECURITIES) 67018T105 (CUSIP NUMBER) 07/31/2023 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE I |
|
| August 2, 2023 |
Exhibit 10.2 AMENDMENT 1 TO FOURTH AMENDED AND RESTATED NU SKIN ENTERPRISES, INC. DEFERRED COMPENSATION PLAN Nu Skin Enterprises, Inc. (the “Company”) previously established the Fourth Amended and Restated Nu Skin Enterprises, Inc. Deferred Compensation Plan (the “Plan”), effective as of January 1, 2022. The Company hereby amends Section 6.5(e) of the Plan to read in its entirety as follows: (e) F |
|
| August 2, 2023 |
Exhibit 10.1 NU SKIN ENTERPRISES, INC. AMENDED AND RESTATED 2009 KEY EMPLOYEE DEATH BENEFIT PLAN 1. Establishment and Purpose. By approval of the Compensation and Human Capital Committee of the Board of Directors of Nu Skin Enterprises, Inc., a Delaware corporation (“NSE”), the 2009 Key Employee Death Benefit Plan is hereby amended and restated to be known as the Nu Skin Enterprises, Inc. Amended |
|
| August 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| August 1, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 1, 2023 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| August 1, 2023 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Second Quarter 2023 Financial Results PROVO, Utah — Aug. 1, 2023 — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second quarter 2023 results in line with expectations. Executive Summary Q2 2023 vs. Prior-year Quarter Revenue: $500.3 million; (11)% • (3)% FX impact or $(16.4) million Earnings Per Share (EPS): $0.54 compared to $ |
|
| July 27, 2023 |
Nu Skin Enterprises Appoints James D. Thomas as Chief Financial Officer Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Appoints James D. Thomas as Chief Financial Officer PROVO, Utah — July 27, 2023 — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the appointment of James D. Thomas as executive vice president and chief financial officer. Thomas has been serving as interim CFO for the past four months and has been the company’s chief accounting officer f |
|
| July 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 24, 2023 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| June 8, 2023 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 7, 2023 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission F |
|
| May 24, 2023 |
EXHIBIT 1.01 NU SKIN ENTERPRISES, INC. 2022 CONFLICT MINERALS REPORT May 24, 2023 We prepared this 2022 Conflict Minerals Report pursuant to Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”), which was promulgated in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 to impose reporting, disclosure and other requirements on registrants that manufa |
|
| May 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 (State or other jurisdiction of incorporation) (Commission File Number) 75 West Center Street Provo, Utah 84601 (Address of principal executive offices and zip code) Gregory Belliston, (801) |
|
| May 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| May 3, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 3, 2023 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission Fi |
|
| May 3, 2023 |
Nu Skin Enterprises Reports First Quarter 2023 Financial Results Company Reiterates 2023 Guidance Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports First Quarter 2023 Financial Results Company Reiterates 2023 Guidance PROVO, Utah — May 3, 2023 — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced first quarter 2023 results in line with expectations. Executive Summary Q1 2023 vs. Prior-year Quarter Revenue: $481.5 million; (20)% • (4)% FX impact or $(29) million Earnings Per Shar |
|
| April 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 14, 2023 |
2022 ANNUAL REPORT TO STOCKHOLDERS ANNUAL REPORT 2022DEAR SHAREHOLDER, This past year was both challenging and instructive as we navigated historic disruptions, including the lingering effects of a global pandemic, hyperinflation, and geo-political conflicts. |
|
| March 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 24, 2023 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| February 16, 2023 |
Exhibit 4.1 CLASS A COMMMON STOCK NUMBER CLASS A COMMON STOCK SHARES CUSIP 67018T 10 5 SEE REVERSE FOR CERTAIN DEFINITIONS NU SKIN ENTERPRISES, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE This Certifies That is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF CLASS A COMMON STOCK OF THE PAR VALUE OF $.001 EACH OF NU SKIN ENTERPRISES transferable only on the books of the Corporati |
|
| February 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| February 16, 2023 |
Exhibit 10.13 NU SKIN ENTERPRISES, INC. THIRD AMENDED AND RESTATED 2010 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT This Restricted Stock Unit Agreement, Participant’s award information (the “Award Summary”), which can be accessed on the Morgan Stanley stock plan website (currently www.stockplanconnect.com) or the website of any other stock plan administrator selected by the Company in |
|
| February 16, 2023 |
EXHIBIT 21.1 SUBSIDIARIES OF THE REGISTRANT Big Planet, Inc., a Delaware corporation Corner Canyon Canada, Inc., an Ontario corporation Corner Canyon Manufacturing, Inc., a Utah corporation Elevate Nutraceuticals LLC, a Utah limited liability company Grōv Technologies, LLC, a Utah limited liability company Grow Solutions Tech LLC, a Utah limited liability company Guangdong Xingchuang Daily-Use & H |
|
| February 16, 2023 |
Exhibit 10.18 NU SKIN ENTERPRISES, INC. EXECUTIVE SEVERANCE POLICY Amended and Restated Effective as of January 4, 2023 TABLE OF CONTENTS PAGE SECTION 1. DEFINITIONS 1 SECTION 2. TERM OF POLICY 5 SECTION 3. TERMINATION BY COMPANY WITHOUT CAUSE OR BY EXECUTIVE FOR GOOD REASON 5 SECTION 4. TERMINATION BY REASON OF DEATH OR DISABILITY 7 SECTION 5. TERMINATION BY THE COMPANY FOR CAUSE 7 SECTION 6. VOL |
|
| February 16, 2023 |
Form of Third Amended and Restated 2010 Plan Restricted Stock Unit Grant Agreement. Exhibit 10.11 NU SKIN ENTERPRISES, INC. THIRD AMENDED AND RESTATED 2010 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT This Restricted Stock Unit Agreement, Participant’s award information (the “Award Summary”), which can be accessed on the Morgan Stanley stock plan website (currently www.stockplanconnect.com) or the website of any other stock plan administrator selected by the Company in |
|
| February 16, 2023 |
Form of Third Amended and Restated 2010 Plan Performance Restricted Stock Unit Grant Agreement. Exhibit 10.12 NU SKIN ENTERPRISES, INC. THIRD AMENDED AND RESTATED 2010 OMNIBUS INCENTIVE PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT This Performance Restricted Stock Unit Agreement, Participant’s award information (the “Award Summary”), which can be accessed on the Morgan Stanley stock plan website (currently www.stockplanconnect.com) or the website of any other stock plan administrator sel |
|
| February 15, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 15, 2023 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commiss |
|
| February 15, 2023 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Fourth Quarter and 2022 Financial Results Company Provides Initial Outlook for Q1 and FY 2023 PROVO, Utah — Feb. 15, 2023 — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced fourth quarter and full year 2022 results. Executive Summary Q4 2022 vs. Prior-year Quarter Revenue: $522.3 million; (22)% • (7)% FX impact or $(51) million Ea |
|
| February 13, 2023 |
NUS / Nu Skin Enterprises, Inc. / RENAISSANCE TECHNOLOGIES LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* NU SKIN ENTERPRISES, INC. - (Name of Issuer) Class A Common Stock, $.001 par value - (Title of Class of Securities) 67018T105 - (CUSIP Number) December 30, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design |
|
| February 9, 2023 |
NUS / Nu Skin Enterprises, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: Nu Skin Enterprises Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 67018T105 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedu |
|
| February 9, 2023 |
NUS / Nu Skin Enterprises, Inc. / STATE STREET CORP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 AMEMDED FILING NU SKIN ENTERPRISES INC (NAME OF ISSUER) COMMON STOCK (TITLE OF CLASS OF SECURITIES) 67018T105 (CUSIP NUMBER) 12/31/2022 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE I |
|
| February 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Nu Skin Enterprises, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 67018T105 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| January 23, 2023 |
NUS / Nu Skin Enterprises, Inc. / BlackRock Inc. Passive Investment SC 13G/A 1 us67018t1051012323.txt us67018t1051012323.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 9) NU SKIN ENTERPRISES INC - (Name of Issuer) Class A Common Stock - (Title of Class of Securities) 67018T105 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the ap |
|
| December 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 20, 2022 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commiss |
|
| December 7, 2022 |
NUS / Nu Skin Enterprises, Inc. / BlackRock Inc. Passive Investment us67018t1051120622.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 8) NU SKIN ENTERPRISES INC - (Name of Issuer) Class A Common Stock - (Title of Class of Securities) 67018T105 - (CUSIP Number) November 30, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rul |
|
| November 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| November 2, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 2, 2022 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissi |
|
| November 2, 2022 |
Nu Skin Enterprises Reports Third Quarter Financial Results Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Third Quarter Financial Results PROVO, Utah ? Nov. 2, 2022 ? Nu Skin Enterprises, Inc. (NYSE: NUS) today announced third quarter 2022 results. Executive Summary Q3 2022 vs. Prior-year Quarter Revenue: $537.8 million; (16)% ? (7)% FX impact or $(47) million Earnings Per Share (EPS): $(0.51) or $0.47 excluding restructuring and impairmen |
|
| August 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| August 4, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 4, 2022 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| August 4, 2022 |
Nu Skin Enterprises Reports Second Quarter Financial Results Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Second Quarter Financial Results PROVO, Utah ? Aug. 4, 2022 ? Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second quarter 2022 results. Executive Summary Q2 2022 vs. Prior-year Quarter Revenue: $560.6 million; (20)% ? (5)% FX impact or $(34.6) million Earnings Per Share (EPS): $0.67 or $0.77 excluding charges associated with o |
|
| July 8, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Provides Estimated Second Quarter Revenue Company to announce full second quarter results and revised guidance Aug. 4 PROVO, Utah ? July 7, 2022 ? Nu Skin Enterprises, Inc. (NYSE: NUS) today announced estimated second quarter revenue between $557 and $562 million. ?Our second quarter revenue was softer than expected due to extended COVID-relat |
|
| July 8, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 7, 2022 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission F |
|
| June 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 14, 2022 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| June 17, 2022 |
Exhibit 10.1 EXECUTION VERSION AMENDMENT AND RESTATEMENT AGREEMENT This AMENDMENT AND RESTATEMENT AGREEMENT, dated as of June 14, 2022 (this ?Restatement Agreement?), in respect of the Credit Agreement, dated as of April 18, 2018 (as amended, supplemented or modified prior to the date hereof and as in effect prior to giving effect to this Restatement Agreement, the ?Credit Agreement?), among Nu Sk |
|
| June 6, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 2, 2022 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission F |
|
| June 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 27, 2022 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission F |
|
| May 27, 2022 |
EX-1.01 2 brhc10038088ex1-01.htm CONFLICT MINERALS REPORT EXHIBIT 1.01 NU SKIN ENTERPRISES, INC. 2021 CONFLICT MINERALS REPORT May 27, 2022 We prepared this 2021 Conflict Minerals Report pursuant to Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”), which was promulgated in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 to impose reporting, di |
|
| May 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 (State or other jurisdiction of incorporation) (Commission File Number) 75 West Center Street Provo, Utah 84601 (Address of principal executive offices and zip code) Gregory Belliston, (801) |
|
| May 10, 2022 |
NUS / Nu Skin Enterprises, Inc. / STATE STREET CORP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 AMENDED FILING NU SKIN ENTERPRISES INC (NAME OF ISSUER) COMMON STOCK (TITLE OF CLASS OF SECURITIES) 67018T105 (CUSIP NUMBER) 04/30/2022 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE I |
|
| May 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| May 4, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 4, 2022 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission Fi |
|
| May 4, 2022 |
Nu Skin Enterprises Reports First Quarter Financial Results Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports First Quarter Financial Results PROVO, Utah ? May 4, 2022 ? Nu Skin Enterprises, Inc. (NYSE: NUS) today announced first quarter 2022 results. Executive Summary Q1 2022 vs. Prior-year Quarter Revenue: $604.9 million; (11)% ? (3)% FX impact or $(17.2) million Earnings Per Share (EPS): $0.76; (16)% Customers: 1,321,451; (13)% Paid Affilia |
|
| April 19, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 19, 2022 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| April 19, 2022 |
Exhibit 99.1 DEAR SHAREHOLDER, 2021 was another year filled with global uncertainty due to COVID-related challenges, economic uncertainty, and global supply chain constraints. However, we at Nu Skin Enterprises delivered revenue and adjusted earnings growth, expanded our leading product portfolio and initiated our strategic transformation plan, Nu Vision 2025. Our committed and talented management |
|
| April 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| February 16, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Fourth Quarter and 2021 Financial Results Company provides initial 2022 outlook and introduces Nu Vision 2025 PROVO, Utah ? Feb. 16, 2022 ? Nu Skin Enterprises, Inc. (NYSE: NUS) today announced fourth quarter and 2021 results. Executive Summary Q4 2021 vs. Prior-year Quarter Revenue: $673.4 million; (10)% ? (2)% fx impact or $(11.9) mi |
|
| February 16, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 16, 2022 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commiss |
|
| February 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| February 16, 2022 |
SUBSIDIARIES OF THE REGISTRANT EXHIBIT 21.1 SUBSIDIARIES OF THE REGISTRANT Big Planet, Inc., a Delaware corporation Corner Canyon Canada, Inc., an Ontario corporation Corner Canyon Manufacturing, Inc., a Utah corporation Elevate Nutraceuticals LLC, a Utah limited liability company Gr?v Technologies, LLC, a Utah limited liability company Grow Solutions Tech LLC, a Utah limited liability company Guangdong Xingchuang Daily-Use & H |
|
| February 16, 2022 |
Exhibit 10.18 FOURTH AMENDED AND RESTATED NU SKIN ENTERPRISES, INC. DEFERRED COMPENSATION PLAN Effective as of January 1, 2022 -i- NU SKIN ENTERPRISES, INC. DEFERRED COMPENSATION PLAN PREAMBLE Nu Skin Enterprises, Inc., (the ?Company?) has previously established the Nu Skin Enterprises, Inc. Deferred Compensation Plan (the ?Plan?). The purpose of the Plan is to provide a select group of management |
|
| February 16, 2022 |
Exhibit 10.20 NU SKIN ENTERPRISES, INC. EXECUTIVE SEVERANCE POLICY Amended and Restated Effective as of October 15, 2020 TABLE OF CONTENTS PAGE SECTION 1. DEFINITIONS 1 SECTION 2. TERM OF POLICY 4 SECTION 3. TERMINATION BY COMPANY WITHOUT CAUSE OR BY EXECUTIVE FOR GOOD REASON 4 SECTION 4. TERMINATION BY REASON OF DEATH OR DISABILITY 6 SECTION 5. TERMINATION BY THE COMPANY FOR CAUSE 7 SECTION 6. VO |
|
| February 16, 2022 |
Exhibit 10.13 NU SKIN ENTERPRISES, INC. THIRD AMENDED AND RESTATED 2010 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT This Restricted Stock Unit Agreement, Participant?s award information (the ?Award Summary?), which can be accessed on the Morgan Stanley stock plan website (currently www.stockplanconnect.com) or the website of any other stock plan administrator selected by the Company in |
|
| February 16, 2022 |
Exhibit 10.14 NU SKIN ENTERPRISES, INC. THIRD AMENDED AND RESTATED 2010 OMNIBUS INCENTIVE PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT This Performance Restricted Stock Unit Agreement, Participant?s award information (the ?Award Summary?), which can be accessed on the Morgan Stanley stock plan website (currently www.stockplanconnect.com) or the website of any other stock plan administrator sel |
|
| February 11, 2022 |
NUS / Nu Skin Enterprises, Inc. / RENAISSANCE TECHNOLOGIES LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* NU SKIN ENTERPRISES, INC. - (Name of Issuer) Class A Common Stock, $.001 par value - (Title of Class of Securities) 67018T105 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design |
|
| February 10, 2022 |
NUS / Nu Skin Enterprises, Inc. / STATE STREET CORP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 INITIAL FILING NU SKIN ENTERPRISES INC (NAME OF ISSUER) COMMON STOCK (TITLE OF CLASS OF SECURITIES) 67018T105 (CUSIP NUMBER) 01/31/2022 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE I |
|
| February 10, 2022 |
NUS / Nu Skin Enterprises, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Nu Skin Enterprises Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 67018T105 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedu |
|
| February 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Nu Skin Enterprises, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 67018T105 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| January 27, 2022 |
NUS / Nu Skin Enterprises, Inc. / BlackRock Inc. Passive Investment us67018t1051012722.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 7) NU SKIN ENTERPRISES INC - (Name of Issuer) Class A Common Stock - (Title of Class of Securities) 67018T105 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rul |
|
| January 26, 2022 |
NUS / Nu Skin Enterprises, Inc. / BlackRock Inc. Passive Investment us67018t1051012522.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 6) NU SKIN ENTERPRISES INC - (Name of Issuer) Class A Common Stock - (Title of Class of Securities) 67018T105 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rul |
|
| January 5, 2022 |
New Year’s Message from CEO Ryan Napierski Exhibit 99.1 New Year’s Message from CEO Ryan Napierski Dear Nu Skin Team: What a year 2021 was! In many respects, the past two years have been some of the most challenging of our collective lifetimes. The lingering global pandemic and associated fatigue continue to disrupt everyone’s lives in various ways, including how we engage, connect, and relate with each other and the world around us. Yet d |
|
| January 5, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 5, 2022 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissio |
|
| December 29, 2021 |
Material Impairments, Costs Associated with Exit or Disposal Activities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 22, 2021 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commiss |
|
| November 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| November 3, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 3, 2021 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissi |
|
| November 3, 2021 |
Nu Skin Enterprises Reports Third Quarter 2021 Results EX-99.1 2 brhc10030354ex99-1.htm PRESS RELEASE DATED NOVEMBER 3, 2021 Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Third Quarter 2021 Results PROVO, Utah — Nov. 3, 2021 — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced third quarter 2021 revenue of $641.2 million and earnings per share (EPS) of $0.97. Executive Summary Q3 2021 vs. Prior-year Quarter Revenue: $641.2 million; |
|
| October 4, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 4, 2021 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissio |
|
| October 4, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Provides Estimated Third Quarter Revenue Company to announce full third quarter results and revised guidance Nov. 3 PROVO, Utah ? Oct. 4, 2021 ? Nu Skin Enterprises, Inc. (NYSE: NUS) today announced estimated third quarter revenue between $637 and $642 million. ?Our third quarter revenue was softer than anticipated as the delta variant created |
|
| August 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 9, 2021 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of inco |
|
| August 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| August 4, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE NU SKIN ENTERPRISES REPORTS 42 PERCENT EPS GROWTH AND 15 PERCENT REVENUE GROWTH IN THE SECOND QUARTER PROVO, Utah ? Aug. 4, 2021 ? Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second-quarter 2021 revenue of $704.1 million and earnings per share (EPS) of $1.15 driven by an increase in operating margin of 260 basis points. Executive Summary Q2 2021 vs. Pri |
|
| August 4, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 4, 2021 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| June 24, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 18, 2021 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| June 3, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 2, 2021 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission F |
|
| May 25, 2021 |
EXHIBIT 1.01 NU SKIN ENTERPRISES, INC. 2020 CONFLICT MINERALS REPORT May 25, 2021 We prepared this 2020 Conflict Minerals Report pursuant to Rule 13p-1 under the Securities Exchange Act of 1934 (the ?Rule?), which was promulgated in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 to impose reporting, disclosure and other requirements on registrants that manufa |
|
| May 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) 75 West Center Street Provo, Utah 84601 (Address of principal executiv |
|
| May 5, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 5, 2021 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission Fi |
|
| May 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| May 5, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE NU SKIN ENTERPRISES REPORTS RECORD FIRST-QUARTER 2021 RESULTS Company announces first-quarter revenue growth of 31% and EPS growth of 153%, raises annual guidance PROVO, Utah ? May 5, 2021 ? Nu Skin Enterprises, Inc. (NYSE: NUS) today announced record first-quarter 2021 revenue and earnings per share. Executive Summary Q1 2021 vs. Prior-year Quarter Revenue: $677 |
|
| May 5, 2021 |
EXHIBIT 10.1 March 22, 2021 Dear Connie, I am excited to offer you the position of EVP, Growth and Customer Experience. In this role, you will report directly to me. Your starting base salary will be $590,000 annually, with an exempt status on an employment at-will basis. In addition, your target bonus will be set at 75% of your base salary and based upon the company?s achievement of its full reve |
|
| April 19, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 19, 2021 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| April 19, 2021 |
Exhibit 99.1 DEAR SHAREHOLDER, As I enter my final year as CEO of Nu Skin, I reflect on a year unlike any other, marked by both significant global challenges as well as incredible opportunities. After 30 years with this extraordinary organization, it is hard to convey how proud I am of our employees and sales leaders worldwide. I am particularly pleased with how they rose to the occasion and respo |
|
| April 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 12, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Nu Skin Enterprises Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 67018T105 Date of Event Which Requires Filing of this Statement: March 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| April 12, 2021 |
- NOTICE OF INTERNET AVAILABILITY UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| February 11, 2021 |
Registration No. 333- As filed with the Securities and Exchange Commission on February 11, 2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S‑8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 87-0565309 (State or other jurisdiction of incorporation or organization) (I. |
|
| February 11, 2021 |
EX-99.1 2 brhc10020071ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE NU SKIN ENTERPRISES REPORTS FOURTH-QUARTER REVENUE GROWTH OF 28 PERCENT AND EPS GROWTH OF 94 PERCENT Company provides strong initial 2021 outlook PROVO, Utah — Feb. 10, 2021 — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced fourth-quarter 2020 results, achieving 28 percent revenue growth and 94 percent earnings |
|
| February 11, 2021 |
Exhibit 10.13 NU SKIN ENTERPRISES, INC. THIRD AMENDED AND RESTATED 2010 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT This Restricted Stock Unit Agreement, Participant’s award information (the “Award Summary”), which can be accessed on the Morgan Stanley stock plan website (currently www.stockplanconnect.com) or the website of any other stock plan administrator selected by the Company in |
|
| February 11, 2021 |
SUBSIDIARIES OF THE REGISTRANT Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT Big Planet, Inc., a Delaware corporation Corner Canyon Canada, Inc., an Ontario corporation Corner Canyon Manufacturing, Inc., a Utah corporation Elevate Nutraceuticals LLC, a Utah limited liability company Grōv Technologies, LLC, a Utah limited liability company Grow Solutions Tech LLC, a Utah limited liability company Guangdong Xingchuang Daily-Use & H |
|
| February 11, 2021 |
Exhibit 10.14 NU SKIN ENTERPRISES, INC. THIRD AMENDED AND RESTATED 2010 OMNIBUS INCENTIVE PLAN PERFORMANCE STOCK OPTION AGREEMENT This Performance Stock Option Agreement, Participant’s award information (the “Award Summary”), which can be accessed on the Morgan Stanley stock plan website (currently www.stockplanconnect.com) or the website of any other stock plan administrator selected by the Compa |
|
| February 11, 2021 |
Exhibit 10.15 NU SKIN ENTERPRISES, INC. THIRD AMENDED AND RESTATED 2010 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT This Restricted Stock Unit Agreement, Participant’s award information (the “Award Summary”), which can be accessed on the Morgan Stanley stock plan website (currently www.stockplanconnect.com) or the website of any other stock plan administrator selected by the Company in |
|
| February 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 8, 2021 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissi |
|
| February 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| February 11, 2021 |
Exhibit 99.2 FOR IMMEDIATE RELEASE NU SKIN ENTERPRISES ANNOUNCES CEO TRANSITION PLAN Nu Skin President Ryan Napierski to become president and CEO on Sept. 1, succeeding Ritch Wood, who will retire as CEO following 30-year career with Nu Skin PROVO, Utah — Feb. 10, 2021 — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced Ryan Napierski, the company’s president, has been selected by the Nu Skin |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Nu Skin Enterprises Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 67018T105 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedul |
|
| February 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 NU SKIN ENTERPRISES, INC. - (Name of Issuer) Class A Common Stock, $.001 par value - (Title of Class of Securities) 67018T105 - (CUSIP Number) November 12, 2020 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua |
|
| February 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Nu Skin Enterprises, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 67018T105 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| January 27, 2021 |
us67018t1051012621.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 5) NU SKIN ENTERPRISES, INC. - (Name of Issuer) Class A Common Stock - (Title of Class of Securities) 67018T105 - (CUSIP Number) December 31, 2020 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the r |
|
| November 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| November 5, 2020 |
Exhibit 10.1 THIRD AMENDED AND RESTATED NU SKIN ENTERPRISES, INC. DEFERRED COMPENSATION PLAN Effective as of January 1, 2021 -i- NU SKIN ENTERPRISES, INC. DEFERRED COMPENSATION PLAN PREAMBLE Nu Skin Enterprises, Inc., (the “Company”) has previously established the Nu Skin Enterprises, Inc. Deferred Compensation Plan (the “Plan”). The purpose of the Plan is to provide a select group of management, |
|
| November 4, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 4, 2020 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissi |
|
| November 4, 2020 |
NU SKIN ENTERPRISES REPORTS THIRD-QUARTER 2020 RESULTS AND RAISES ANNUAL GUIDANCE Exhibit 99.1 FOR IMMEDIATE RELEASE NU SKIN ENTERPRISES REPORTS THIRD-QUARTER 2020 RESULTS AND RAISES ANNUAL GUIDANCE PROVO, Utah — Nov. 4, 2020 — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced third-quarter results of 19 percent revenue growth and 37 percent earnings per share growth and raised its guidance for 2020. Executive Summary Q3 2020 vs. Prior-Year Quarter Revenue: $703.3 million; |
|
| October 20, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 15, 2020 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissi |
|
| October 20, 2020 |
Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into effective as of 2020‑10‑15 (the “Effective Date”) by and between Nu Skin Enterprises, Inc., a Delaware corporation (the “Company”) and Joseph Y. Chang, an individual (the “Executive”). WHEREAS, the Executive has been employed since May 17, 1997 by the Company or one of its affiliates; WHEREAS, the Execut |
|
| October 20, 2020 |
Exhibit 10.2 NU SKIN ENTERPRISES, INC. EXECUTIVE SEVERANCE POLICY Amended and Restated Effective as of October 15, 2020 TABLE OF CONTENTS PAGE SECTION 1. DEFINITIONS 1 SECTION 2. TERM OF POLICY 3 SECTION 3. TERMINATION BY COMPANY WITHOUT CAUSE OR BY EXECUTIVE FOR GOOD REASON 3 SECTION 4. TERMINATION BY REASON OF DEATH OR DISABILITY 5 SECTION 5. TERMINATION BY THE COMPANY FOR CAUSE 6 SECTION 6. VOL |
|
| October 2, 2020 |
Exhibit 99.1 FOR IMMEDIATE RELEASE NU SKIN ENTERPRISES REPORTS ESTIMATED THIRD-QUARTER REVENUE SIGNIFICANTLY ABOVE PREVIOUS GUIDANCE Revenue increase driven by continued adoption of digitally enabled business resulting in strong sales leader and customer growth Company to release full results for third quarter on Nov. 4 PROVO, Utah — Oct. 1, 2020 — Nu Skin Enterprises, Inc. (NYSE: NUS) today estim |
|
| October 2, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 1, 2020 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commissio |
|
| August 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
|
| August 5, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 5, 2020 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission |
|
| August 5, 2020 |
NU SKIN ENTERPRISES REPORTS SECOND-QUARTER 2020 RESULTS AND RAISES 2020 GUIDANCE Exhibit 99.1 FOR IMMEDIATE RELEASE NU SKIN ENTERPRISES REPORTS SECOND-QUARTER 2020 RESULTS AND RAISES 2020 GUIDANCE PROVO, Utah — Aug. 5, 2020 — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second-quarter results above expectations and raised its revenue and earnings per share guidance for 2020. Executive Summary Q2 2020 vs. Prior-Year Quarter Revenue: $612.4 million; (2%) • (3%) fx impac |
|
| July 1, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 1, 2020 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission F |
|
| July 1, 2020 |
Exhibit 99.1 FOR IMMEDIATE RELEASE NU SKIN ENTERPRISES REPORTS ESTIMATED SECOND-QUARTER REVENUE ABOVE PREVIOUS GUIDANCE Company experiencing stronger than expected global customer growth and accelerated digital adoption; second-quarter earnings release scheduled for Aug. 5 PROVO, Utah — July 1, 2020 — Nu Skin Enterprises, Inc. (NYSE: NUS) today reported it estimates revenue for the second quarter |
|
| June 4, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 3, 2020 Date of Report (Date of earliest event reported) NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission F |
|
| June 3, 2020 |
Registration No. 333-136464 As filed with the Securities and Exchange Commission on June 3, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S‑8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 87-0565309 (State or other jurisdiction of |
|
| June 3, 2020 |
EXHIBIT 99.1 THIRD AMENDED AND RESTATED 2010 OMNIBUS INCENTIVE PLAN Stockholder Approval: June 3, 2020 Expiration Date: June 3, 2030 Nu Skin Enterprises, Inc. (the “Company”), a Delaware corporation, hereby establishes and adopts the following Third Amended and Restated 2010 Omnibus Incentive Plan (the “Plan”). 1 PURPOSE OF THE PLAN The purpose of the Plan is to assist the Company and its Subsidia |
|
| June 3, 2020 |
Registration No. 333- As filed with the Securities and Exchange Commission on June 3, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S‑8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 87-0565309 (State or other jurisdiction of incorporation or organization) (I.R.S. |
|
| May 20, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| May 19, 2020 |
EXHIBIT 1.01 NU SKIN ENTERPRISES, INC. 2019 CONFLICT MINERALS REPORT May 19, 2020 We prepared this 2019 Conflict Minerals Report pursuant to Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”), which was promulgated in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 to impose reporting, disclosure and other requirements on registrants that manufa |
|
| May 19, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12421 87-0565309 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) 75 West Center Street Provo, Utah 84601 (Address of principal executiv |
|
| May 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. |
